US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 3.5100
  • +0.2400+7.34%
Close Nov 8 16:00 ET
32.39MMarket Cap-557P/E (TTM)

SAB Biotherapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Oct 31, 2024

Based on 4 analysts giving stock ratings to SAB Biotherapeutics in the past 3 months

Strong Buy

  • Buy

    100.00%

  • Hold

    0.00%

  • Sell

    0.00%

Price Target

Updated: Oct 31, 2024

The average SAB Biotherapeutics stock price target is 13.50 with a max estimate of 25.00 and a min estimate of 6.00

Review SAB Biotherapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Oct 31, 2024

Strong Buy

  • Buy

    100.00%

  • Hold

    0.00%

  • Sell

    0.00%

Price Target

Updated: Oct 31, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data